{
  "id": "601ebbeb1cb411341a00005b",
  "type": "factoid",
  "question": "What syndrome is associated with mutations in lysine methyltransferase 2D KMT2D?",
  "ideal_answer": "Mutations in lysine methyltransferase 2D (KMT2D) cause Kabuko syndrome.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/28475860",
    "http://www.ncbi.nlm.nih.gov/pubmed/24705355",
    "http://www.ncbi.nlm.nih.gov/pubmed/28007623",
    "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
    "http://www.ncbi.nlm.nih.gov/pubmed/31813957",
    "http://www.ncbi.nlm.nih.gov/pubmed/24838796",
    "http://www.ncbi.nlm.nih.gov/pubmed/30980591",
    "http://www.ncbi.nlm.nih.gov/pubmed/29725259",
    "http://www.ncbi.nlm.nih.gov/pubmed/31282990",
    "http://www.ncbi.nlm.nih.gov/pubmed/31465303",
    "http://www.ncbi.nlm.nih.gov/pubmed/29914387",
    "http://www.ncbi.nlm.nih.gov/pubmed/27573763",
    "http://www.ncbi.nlm.nih.gov/pubmed/30891914",
    "http://www.ncbi.nlm.nih.gov/pubmed/32803813",
    "http://www.ncbi.nlm.nih.gov/pubmed/26194542",
    "http://www.ncbi.nlm.nih.gov/pubmed/31816409",
    "http://www.ncbi.nlm.nih.gov/pubmed/26932671",
    "http://www.ncbi.nlm.nih.gov/pubmed/32083401",
    "http://www.ncbi.nlm.nih.gov/pubmed/24240169"
  ],
  "snippets": [
    {
      "text": "Kabuki syndrome (KS) is commonly caused by mutations in the histone-modifying enzyme lysine methyltransferase 2D (KMT2D). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31816409",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Kabuki syndrome (KS) is a rare congenital disorder characterized by distinctive facies, postnatal growth deficiency, cardiac defects and skeletal anomalies. Studies have determined that pathogenic variants of the lysine-specific methyltransferase 2D (KMT2D) and lysine-specific demethylase 6A (KDM6A) genes are the major causes of KS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31935506",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Pathogenic variants in KMT2D, which encodes lysine specific methyltransferase 2D, cause autosomal dominant Kabuki syndrome, associated with distinctive dysmorphic features including arched eyebrows, long palpebral fissures with eversion of the lower lid, large protuberant ears, and fetal finger pads",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32083401",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We describe here four patients (including one previously published patient) with de novo KMT2D missense variants and with shared but unusual clinical findings not typically seen in Kabuki syndrome",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32083401",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "These findings significantly expand the phenotypic spectrum of features associated with variants in KMT2D beyond those seen in Kabuki syndrome and suggest a possible new underlying disease mechanism for these patients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32083401",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kabuki syndrome is characterized by a variable degree of intellectual disability, characteristic facial features, and complications in various organs. Many variants have been identified in two causative genes, that is, lysine methyltransferase 2D (KMT2D) and lysine demethylase 6A (KDM6A)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32803813",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Heterozygous germline mutations in the KMT2D gene are known to cause Kabuki syndrome (OMIM 147920), a developmental multisystem disorder. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31282990",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Lysine-specific methyltransferase 2D (KMT2D) encodes a histone methyltransferase that promotes transcriptional activation and is frequently mutated in cancers and in the majority (>70%) of patients diagnosed with the congenital, multisystem intellectual disability disorder Kabuki syndrome 1 (KS1). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31465303",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Kabuki syndrome is caused by mutations or deletions of lysine (K)-specific methyltransferase 2D (KMT2D) and lysine-specific methylase 6A (KDM6A).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24838796",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Kabuki syndrome (KS) is commonly caused by mutations in the histone-modifying enzyme lysine methyltransferase 2D (KMT2D).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31816409",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "JECTIVE: We sought to characterize the humoral immune defects found in patients with KS with lysine methyltransferase 2D (KMT2D) mutations.ME",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26194542",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "LTS: We report frequent mutations in the lysine methyltransferase 2D gene (KMT2D) (also known as MLL2), a key regulator of transcriptional enhancer function. KMT",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28007623",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ound that KMT2D mutation in human SCLC cell lines was associated with reduced lysine methyltransferase 2D protein levels and reduced monomethylation of histone H3 lysine 4, a mark associated with transcriptional enhancers. We ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28007623",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Two such disorders, CHARGE and Kabuki syndromes, result from loss of function mutations in chromodomain helicase DNA-binding protein\u00a07 (CHD7LOF) and lysine (K) methyltransferase 2D (KMT2DLOF), respectively. Although these two syndromes are clinically",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28475860",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ONS: In patients with KS, autosomal dominant KMT2D mutations are associated with dysregulation of terminal B-cell differentiation, leading to humoral immune deficiency and, in some cases, autoimmunity. All pat",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26194542",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "MT2D has emerged as one of the most frequently mutated genes in a variety of cancers and in other human diseases, including lymphoma, medulloblastoma, gastric cancer, and Kabuki syndrome. Mutations in KMT",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24240169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " KS was confirmed by genetic testing, which revealed a nonsense mutation in exon\u00a016 of KMT2D (c.4485C>A, Tyr1495Ter). To the best of our",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27573763",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Pathogenic variants in KMT2D, which encodes lysine specific methyltransferase 2D, cause autosomal dominant Kabuki syndrome, associated with distinctive dysmorphic features including arched eyebrows, long palpebral fissures with eversion of the lower lid, large protuberant ears, and fetal finger pads.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32083401",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We describe here four patients (including one previously published patient) with de novo KMT2D missense variants and with shared but unusual clinical findings not typically seen in Kabuki syndrome, including athelia (absent nipples), choanal atresia, hypoparathyroidism, delayed or absent pubertal development, and extreme short stature.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32083401",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "KMT2D, which encodes a histone H3K4 methyltransferase, has been implicated in human congenital heart disease in the context of Kabuki syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26932671",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Heterozygous germline mutations in the KMT2D gene are known to cause Kabuki syndrome (OMIM 147920), a developmental multisystem disorder.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31282990",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Despite more than 350 documented cases, the oro-dental spectrum associated with kabuki syndrome and expression of KMT2D (histone-lysine N-methyltransferase 2D) or KDM6A (lysine-specific demethylase 6A) genes in tooth development have not been well defined.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29725259",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "e sought to characterize the humoral immune defects found in patients with KS with lysine methyltransferase 2D (KMT2D) mutations.ME",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26194542",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "atients with KS, autosomal dominant KMT2D mutations are associated with dysregulation of terminal B-cell differentiation, leading to humoral immune deficiency and, in some cases, autoimmunity. All",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26194542",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations in the KMT2D gene, which encodes a H3K4 histone methyltransferase, are the major cause of Kabuki syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24705355",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The major cause of Kabuki syndrome are mutations in KMT2D, a gene encoding a histone H3 lysine 4 (H3K4) methyltransferase belonging to the group of chromatin modifiers.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31813957",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mutations with a loss-of-function in the KMT2D gene on chromosome 12 in humans are responsible for Kabuki syndrome (KS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30891914",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "rt defects. Mutations in the histone H3K4 methyltransferase KMT2D have been identified as the main cause of Kabuki syndrome, however, the role of KMT2D in heart development remains to be characterized.RESULTS: Here we analyze the function of Kmt2d at different stages of Xenop",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30980591",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The histone methyltransferase KMT2D, mutated in Kabuki syndrome patients, is required for neural crest cell formation and migration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31813957",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "A novel KMT2D mutation resulting in Kabuki syndrome: A case report.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27573763",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Recently, KMT2D has emerged as one of the most frequently mutated genes in a variety of cancers and in other human diseases, including lymphoma, medulloblastoma, gastric cancer, and Kabuki syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24240169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A de novo KMT2D mutation in a girl with Kabuki syndrome associated with endocrine symptoms: a case report.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29914387",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Kabuki syndrome"
}